| abstract |
A method of treating a human or non-human animal body is described to treat or prevent fibrin-dependent microcirculation disorders, for example microcirculation disorders caused by metabolic diseases, inflammatory reactions or autoimmune diseases, and also microcirculation disorders. peripheral or microcirculation disorders associated with increased cell fragmentation, which method comprises administering to an human or non-human animal body, such treatment needs an effective amount of a pharmaceutical composition containing a pyrimido-pyrimidine selected from dipyridamole, mopidamol and the pharmaceutically acceptable salts thereof, and the use of said pyrimido-pyrimidine for the manufacture of a corresponding pharmaceutical formulation. |